i
Investing to protect the United States and the world against AR
-
02/09/2023
-
[PDF-259.95 KB]
Details:
-
Corporate Authors:
-
Description:Antimicrobial resistance (AR), when germs do not respond to the drugs designed to kill them, threatens to return us to the time when simple infections were often fatal. CDC is committed to protecting people and the future of the healthcare, veterinary, and agriculture industries from the threat of antimicrobial resistance.
The AR Investment Map showcases CDC’s critical activities in the U.S. and abroad to combat AR with investments in laboratory and epidemiological expertise and public health innovation. CDC supports most of these activities through its AR Solutions Initiative, while also leveraging investments from successful programs across the agency for maximum efficiency. The map also includes activities supported by supplemental funding provided to CDC to support response to the COVID-19 pandemic, highlighted in a fact sheet.
Since 2016, CDC has supported comprehensive AR work in the U.S. and leveraged lessons learned for local solutions abroad.
• Projects in the U.S. and more than 60 countries abroad
• Nearly $731 million to 59 state and local health departments
• Supporting 500+ local AR experts
• AR Lab Network has detected about 29,000 resistant germs that required investigation
Publication date from document properties.
Utah-CDC-AR-Investments.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Pages in Document:1 numbered page
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
